Home > products > custom-nanocomposites
> lipid-nanoparticle-composite-materials
> crgd-modified-bi2se3-nanoparticles-drugs-sn38-ir820
CRGD modified Bi2Se3 nanoparticles@drugs SN38 and IR820
CRGD modified Bi2Se3 nanoparticles loaded with drugs SN38 and IR820
Product description
CRGD modified Bi2Se3 nanoparticles@drugs SN38 and IR820 are a multifunctional nanomedicine system that integrates active targeting, chemotherapy photothermal synergistic therapy, aiming to improve the precision and efficacy of tumor treatment.
| Appearance | Freeze-dried powder |
|---|---|
| Size | ±100nm |
| Solubility | N/A |
| Drug loading | 5.3%(SN38);1.1.9%(IR820) |
| Encapsulation efficiency | 66.52%(SN38);63.33%(IR820) |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 1-3 weeks |
| Stability | 6 months |
Document
Related Product

Items-$0.00

Email:
Tel.:
MSDS OF CRGD modified Bi2Se3 nanoparticles@drugs SN38 and IR820
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


